Uma candidatura completa num minuto
Currículo e carta de apresentação personalizados, prontos a enviar.
Pharmaron, a global CRO/CDMO, is seeking a Senior Oncology Specialist to provide disease-area leadership across Integrated Drug Discovery. The role will help project teams convert oncology insight into practical discovery plans with emphasis on biological rationale, model selection, translational endpoints and evidence packages that support programme decisions.
This position suits an experienced oncology scientist or clinician-scientist who can combine deep disease knowledge with pragmatic
The following content displays a map of the jobs location - Remote
Location: UK or US preferred; hybrid or remote working considered
Pharmaron is a global contract research and manufacturing organization (CRO/CDMO)helping pharma and biotech companies bring new therapies to life. With over 25,000 employees worldwide across 28 locations in the UK, US, China, and Singapore, we support drug discovery through to manufacturing with fully integrated high-quality services.
We're proud of the impact we make and just last year, we supported 887 discovery projects, 1,100+ CMC programs, and 1,397 clinical trialsacross all phases. Our teams are involved in everything from small molecules, ADC's, biologics, and gene therapies and we work with more than 3,300 global customers. To learn more, visit www.pharmaron.com
Pharmaron is looking to appoint a Senior Oncology Specialist to provide disease-area leadership across our Integrated Drug Discovery activities. The role will help project teams and clients convert oncology insight into practical discovery plans, with particular emphasis on biological rationale, model selection, translational endpoints and evidence packages that support clear programme decisions.
This position would suit an experienced oncology scientist or clinician-scientist who can combine deep disease knowledge with a pragmatic understanding of drug discovery. The successful candidate will work across Pharmaron's global scientific network and with external partners to strengthen programme design, interpret complex datasets and identify opportunities to improve how oncology projects are progressed from early concept towards candidate selection and IND preparation.